148 related articles for article (PubMed ID: 36961853)
1. Sociodemographic Variables Can Guide Prioritized Testing Strategies for Epidemic Control in Resource-Limited Contexts.
Evans MV; Ramiadantsoa T; Kauffman K; Moody J; Nunn CL; Rabezara JY; Raharimalala P; Randriamoria TM; Soarimalala V; Titcomb G; Garchitorena A; Roche B
J Infect Dis; 2023 Nov; 228(9):1189-1197. PubMed ID: 36961853
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
[TBL] [Abstract][Full Text] [Related]
3. A network-based model to explore the role of testing in the epidemiological control of the COVID-19 pandemic.
Cui Y; Ni S; Shen S
BMC Infect Dis; 2021 Jan; 21(1):58. PubMed ID: 33435892
[TBL] [Abstract][Full Text] [Related]
4. Optimizing COVID-19 surveillance in long-term care facilities: a modelling study.
Smith DRM; Duval A; Pouwels KB; Guillemot D; Fernandes J; Huynh BT; Temime L; Opatowski L;
BMC Med; 2020 Dec; 18(1):386. PubMed ID: 33287821
[TBL] [Abstract][Full Text] [Related]
5. Flexible, Freely Available Stochastic Individual Contact Model for Exploring COVID-19 Intervention and Control Strategies: Development and Simulation.
Churches T; Jorm L
JMIR Public Health Surveill; 2020 Sep; 6(3):e18965. PubMed ID: 32568729
[TBL] [Abstract][Full Text] [Related]
6. Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
Teslya A; Pham TM; Godijk NG; Kretzschmar ME; Bootsma MCJ; Rozhnova G
PLoS Med; 2020 Jul; 17(7):e1003166. PubMed ID: 32692736
[TBL] [Abstract][Full Text] [Related]
7. Optimizing the nucleic acid screening strategy to mitigate regional outbreaks of SARS-CoV-2 Omicron variant in China: a modeling study.
Yin Y; Liu Y; Duan M; Xie X; Hong J; Huang J; Li K; Shi J; Chen X; Guo H; Zhou X; Liu R; Zhou C; Wang X; Kong L; Zhang Z
Infect Dis Poverty; 2023 Jan; 12(1):1. PubMed ID: 36642738
[TBL] [Abstract][Full Text] [Related]
8. Assessing the feasibility and effectiveness of household-pooled universal testing to control COVID-19 epidemics.
Libin PJK; Willem L; Verstraeten T; Torneri A; Vanderlocht J; Hens N
PLoS Comput Biol; 2021 Mar; 17(3):e1008688. PubMed ID: 33690626
[TBL] [Abstract][Full Text] [Related]
9. Modelling of hypothetical SARS-CoV-2 point-of-care tests on admission to hospital from A&E: rapid cost-effectiveness analysis.
Stevenson M; Metry A; Messenger M
Health Technol Assess; 2021 Mar; 25(21):1-68. PubMed ID: 33764295
[TBL] [Abstract][Full Text] [Related]
10. Estimated Transmission Outcomes and Costs of SARS-CoV-2 Diagnostic Testing, Screening, and Surveillance Strategies Among a Simulated Population of Primary School Students.
Bilinski A; Ciaranello A; Fitzpatrick MC; Giardina J; Shah M; Salomon JA; Kendall EA
JAMA Pediatr; 2022 Jul; 176(7):679-689. PubMed ID: 35442396
[TBL] [Abstract][Full Text] [Related]
11. Efficient vaccination strategies for epidemic control using network information.
Yang Y; McKhann A; Chen S; Harling G; Onnela JP
Epidemics; 2019 Jun; 27():115-122. PubMed ID: 30878314
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Cocirculating Pathogens on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Coronavirus Disease 2019 Surveillance: How Concurrent Epidemics May Introduce Bias and Decrease the Observed SARS-CoV-2 Percentage Positivity.
Kovacevic A; Eggo RM; Baguelin M; Domenech de Cellès M; Opatowski L
J Infect Dis; 2022 Jan; 225(2):199-207. PubMed ID: 34514500
[TBL] [Abstract][Full Text] [Related]
13. Social network analysis methods for exploring SARS-CoV-2 contact tracing data.
Nagarajan K; Muniyandi M; Palani B; Sellappan S
BMC Med Res Methodol; 2020 Sep; 20(1):233. PubMed ID: 32942988
[TBL] [Abstract][Full Text] [Related]
14. Transmission dynamics and control of two epidemic waves of SARS-CoV-2 in South Korea.
Ryu S; Ali ST; Noh E; Kim D; Lau EHY; Cowling BJ
BMC Infect Dis; 2021 May; 21(1):485. PubMed ID: 34039296
[TBL] [Abstract][Full Text] [Related]
15. Surveillance-based informative testing for detection and containment of SARS-CoV-2 outbreaks on a public university campus: an observational and modelling study.
Rennert L; McMahan C; Kalbaugh CA; Yang Y; Lumsden B; Dean D; Pekarek L; Colenda CC
Lancet Child Adolesc Health; 2021 Jun; 5(6):428-436. PubMed ID: 33751952
[TBL] [Abstract][Full Text] [Related]
16. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
[TBL] [Abstract][Full Text] [Related]
17. Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic.
Furuse Y
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564325
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.
Reddy KP; Shebl FM; Foote JHA; Harling G; Scott JA; Panella C; Fitzmaurice KP; Flanagan C; Hyle EP; Neilan AM; Mohareb AM; Bekker LG; Lessells RJ; Ciaranello AL; Wood R; Losina E; Freedberg KA; Kazemian P; Siedner MJ
Lancet Glob Health; 2021 Feb; 9(2):e120-e129. PubMed ID: 33188729
[TBL] [Abstract][Full Text] [Related]
19. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
[TBL] [Abstract][Full Text] [Related]
20. Determinants of SARS-CoV-2 nasopharyngeal testing in a rural community sample susceptible of first infection: the CHRIS COVID-19 study.
Giardiello D; Melotti R; Barbieri G; Gögele M; Weichenberger CX; Foco L; Bottigliengo D; Barin L; Lundin R; Pramstaller PP; Pattaro C
Pathog Glob Health; 2023 Dec; 117(8):744-753. PubMed ID: 36992656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
